Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
ASCO Annual meetingASCO Annual meeting
Not Confirmed
Not Confirmed
30 May-03 June, 2025
ISPE BiotechnologyISPE Biotechnology
Not Confirmed
Not Confirmed
02-03 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
ASCO Annual meetingASCO Annual meeting
Industry Trade Show
Not Confirmed
30 May-03 June, 2025
ISPE BiotechnologyISPE Biotechnology
Industry Trade Show
Not Confirmed
02-03 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
19 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/19/2948703/0/en/U-S-grants-Vidac-Pharma-patent-offering-broad-protection-of-mode-of-action-underlying-its-oncology-drug-candidates.html
24 Jul 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/07/25/2918498/0/en/Vidac-Pharma-publishes-results-of-next-generation-drug-candidate-tests-in-human-and-murine-tumor-models.html
03 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/03/2891897/0/en/Vidac-Pharma-receives-US-patent-office-Notice-of-Allowance-for-crucial-compounds-in-its-cancer-drug-candidates.html
27 Mar 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/03/27/2852896/0/en/Vidac-Pharma-receives-Japanese-Patent-Office-Notice-of-Allowance-for-VDA-1275-cancer-drug-candidate.html
12 Mar 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/03/12/2844278/0/en/Vidac-Pharma-secures-approval-for-next-phase-of-clinical-study-of-lead-asset-in-Cutaneous-T-Cell-Lymphoma.html
19 Feb 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/02/19/2831055/0/en/Vidac-Pharma-presents-high-efficacy-in-multiple-solid-tumor-models-for-its-next-generation-cancer-drug-candidate-and-synergy-with-standard-of-care-treatment-in-liver-cancer-organoi.html
ABOUT THIS PAGE